PF4 and pulmonary fibrosis: Furthermore, both blocking CXCL4 and deleting the CXCL4 gene reduce skin and lung fibrosis in a mouse model of the disease using bleomycin [79], which confirms the role of CXCL4 in disease pathogenesis.